
Sandra E. Dillahunt
Examiner (ID: 6108)
| Most Active Art Unit | 1646 |
| Art Unit(s) | 1646, 1674 |
| Total Applications | 498 |
| Issued Applications | 243 |
| Pending Applications | 21 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7696675
[patent_doc_number] => 20110229915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE'
[patent_app_type] => utility
[patent_app_number] => 13/130474
[patent_app_country] => US
[patent_app_date] => 2009-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 59
[patent_no_of_words] => 21847
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0229/20110229915.pdf
[firstpage_image] =>[orig_patent_app_number] => 13130474
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/130474 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | Nov 20, 2009 | Abandoned |
Array
(
[id] => 9589077
[patent_doc_number] => 08778615
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Methods and compositions for diagnosis and prognosis of renal injury and renal failure'
[patent_app_type] => utility
[patent_app_number] => 13/125360
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 341
[patent_figures_cnt] => 8
[patent_no_of_words] => 26724
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 175
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125360
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125360 | Methods and compositions for diagnosis and prognosis of renal injury and renal failure | Oct 20, 2009 | Issued |
Array
(
[id] => 6047567
[patent_doc_number] => 20110207161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE'
[patent_app_type] => utility
[patent_app_number] => 13/125454
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 138
[patent_figures_cnt] => 138
[patent_no_of_words] => 23623
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207161.pdf
[firstpage_image] =>[orig_patent_app_number] => 13125454
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125454 | METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE | Oct 20, 2009 | Abandoned |
Array
(
[id] => 6313669
[patent_doc_number] => 20100111853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'ANTIBODIES THAT BIND TO IL-12 AND METHODS OF PURIFYING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/582434
[patent_app_country] => US
[patent_app_date] => 2009-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 29818
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111853.pdf
[firstpage_image] =>[orig_patent_app_number] => 12582434
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/582434 | ANTIBODIES THAT BIND TO IL-12 AND METHODS OF PURIFYING THE SAME | Oct 19, 2009 | Abandoned |
Array
(
[id] => 7817470
[patent_doc_number] => 20120064090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'THERAPEUTIC AGENT FOR CANCER HAVING REDUCED SENSITIVITY TO MOLECULAR TARGET DRUG AND PHARMACEUTICAL COMPOSITION FOR ENHANCING SENSITIVITY TO MOLECULAR TARGET DRUG'
[patent_app_type] => utility
[patent_app_number] => 13/258718
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9550
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20120064090.pdf
[firstpage_image] =>[orig_patent_app_number] => 13258718
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/258718 | THERAPEUTIC AGENT FOR CANCER HAVING REDUCED SENSITIVITY TO MOLECULAR TARGET DRUG AND PHARMACEUTICAL COMPOSITION FOR ENHANCING SENSITIVITY TO MOLECULAR TARGET DRUG | Oct 8, 2009 | Abandoned |
Array
(
[id] => 13182199
[patent_doc_number] => 10106601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-23
[patent_title] => Inhibition of PLGF to treat philadelphia chromosome positive leukemia
[patent_app_type] => utility
[patent_app_number] => 13/122137
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 7
[patent_no_of_words] => 17905
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13122137
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122137 | Inhibition of PLGF to treat philadelphia chromosome positive leukemia | Oct 1, 2009 | Issued |
Array
(
[id] => 8370122
[patent_doc_number] => 20120219511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-30
[patent_title] => 'ORAL CARE COMPOSITIONS CONTAINING HUMAN RECOMBINANT INTERLEUKIN-1'
[patent_app_type] => utility
[patent_app_number] => 13/395688
[patent_app_country] => US
[patent_app_date] => 2009-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3939
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13395688
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/395688 | ORAL CARE COMPOSITIONS CONTAINING HUMAN RECOMBINANT INTERLEUKIN-1 | Sep 28, 2009 | Abandoned |
Array
(
[id] => 6114990
[patent_doc_number] => 20110190680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-04
[patent_title] => 'Self-Regulating Device for Modulating Inflammation'
[patent_app_type] => utility
[patent_app_number] => 13/121013
[patent_app_country] => US
[patent_app_date] => 2009-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 18207
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20110190680.pdf
[firstpage_image] =>[orig_patent_app_number] => 13121013
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/121013 | Self-Regulating Device for Modulating Inflammation | Sep 28, 2009 | Abandoned |
Array
(
[id] => 8043325
[patent_doc_number] => 20120071405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-22
[patent_title] => 'COMPOSITION OF INHIBITING PATHOLOGICAL ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 13/120101
[patent_app_country] => US
[patent_app_date] => 2009-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 5543
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20120071405.pdf
[firstpage_image] =>[orig_patent_app_number] => 13120101
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/120101 | COMPOSITION OF INHIBITING PATHOLOGICAL ANGIOGENESIS | Sep 21, 2009 | Abandoned |
Array
(
[id] => 6164861
[patent_doc_number] => 20110195068
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-11
[patent_title] => 'PD-1 ANTAGONISTS AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/060998
[patent_app_country] => US
[patent_app_date] => 2009-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 29954
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0195/20110195068.pdf
[firstpage_image] =>[orig_patent_app_number] => 13060998
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/060998 | PD-1 ANTAGONISTS AND METHODS OF USE THEREOF | Aug 24, 2009 | Abandoned |
Array
(
[id] => 7499481
[patent_doc_number] => 20110262453
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-27
[patent_title] => 'Markers for Assessing the Susceptibility of Cancer to IGF-1R Treatment'
[patent_app_type] => utility
[patent_app_number] => 13/059931
[patent_app_country] => US
[patent_app_date] => 2009-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13313
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20110262453.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059931
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059931 | Markers for Assessing the Susceptibility of Cancer to IGF-1R Treatment | Aug 19, 2009 | Abandoned |
Array
(
[id] => 6047519
[patent_doc_number] => 20110207120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-25
[patent_title] => 'WNT1 AS A RENAL DAMAGE BIOMARKER'
[patent_app_type] => utility
[patent_app_number] => 13/059036
[patent_app_country] => US
[patent_app_date] => 2009-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6996
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20110207120.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059036
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059036 | WNT1 AS A RENAL DAMAGE BIOMARKER | Aug 11, 2009 | Abandoned |
Array
(
[id] => 6016462
[patent_doc_number] => 20110224135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'USE OF CONKUNITZIN-S1 FOR THE MODULATION OF GLUCOSE-INDUCED INSULIN SECRETION'
[patent_app_type] => utility
[patent_app_number] => 13/057809
[patent_app_country] => US
[patent_app_date] => 2009-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15650
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0224/20110224135.pdf
[firstpage_image] =>[orig_patent_app_number] => 13057809
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/057809 | USE OF CONKUNITZIN-S1 FOR THE MODULATION OF GLUCOSE-INDUCED INSULIN SECRETION | Aug 9, 2009 | Abandoned |
Array
(
[id] => 7573088
[patent_doc_number] => 20110268744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-03
[patent_title] => 'Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor'
[patent_app_type] => utility
[patent_app_number] => 12/994714
[patent_app_country] => US
[patent_app_date] => 2009-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 135
[patent_figures_cnt] => 135
[patent_no_of_words] => 93453
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0268/20110268744.pdf
[firstpage_image] =>[orig_patent_app_number] => 12994714
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/994714 | Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor | May 25, 2009 | Abandoned |
Array
(
[id] => 5984463
[patent_doc_number] => 20110097309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue'
[patent_app_type] => utility
[patent_app_number] => 12/990060
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 11511
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097309.pdf
[firstpage_image] =>[orig_patent_app_number] => 12990060
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/990060 | Pharmaceutical Agent for Promoting the Functional Regeneration of Damaged Tissue | Apr 29, 2009 | Abandoned |
Array
(
[id] => 5495357
[patent_doc_number] => 20090263385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Breast carcinoma treatment method'
[patent_app_type] => utility
[patent_app_number] => 12/383320
[patent_app_country] => US
[patent_app_date] => 2009-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16387
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0263/20090263385.pdf
[firstpage_image] =>[orig_patent_app_number] => 12383320
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/383320 | Breast carcinoma treatment method | Mar 22, 2009 | Abandoned |
Array
(
[id] => 6503853
[patent_doc_number] => 20100094560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 12/253177
[patent_app_country] => US
[patent_app_date] => 2008-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 44103
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20100094560.pdf
[firstpage_image] =>[orig_patent_app_number] => 12253177
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/253177 | METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME | Oct 15, 2008 | Abandoned |
Array
(
[id] => 11772414
[patent_doc_number] => 09381166
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-05
[patent_title] => 'Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength'
[patent_app_type] => utility
[patent_app_number] => 12/681352
[patent_app_country] => US
[patent_app_date] => 2008-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 22833
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12681352
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/681352 | Systemic pro-hemostatic effect of sympathicomimetics with agonistic effects on alfa-adrenergic and/or beta-adrenergic receptors of the sympathetic nervous system, related to improved clot strength | Sep 30, 2008 | Issued |
Array
(
[id] => 4807467
[patent_doc_number] => 20080171045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Compositions and Methods for Diagnosing and Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/951039
[patent_app_country] => US
[patent_app_date] => 2007-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24385
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171045.pdf
[firstpage_image] =>[orig_patent_app_number] => 11951039
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/951039 | Compositions and methods for diagnosing and treating cancer | Dec 4, 2007 | Issued |
Array
(
[id] => 4692753
[patent_doc_number] => 20080085524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 11/838810
[patent_app_country] => US
[patent_app_date] => 2007-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 41187
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085524.pdf
[firstpage_image] =>[orig_patent_app_number] => 11838810
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/838810 | METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME | Aug 13, 2007 | Abandoned |